Mitogenic signaling cascades in glial tumors
Related Experiment Video
Updated: Sep 26, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Gurpreet S Kapoor1, Donald M O'Rourke
1Department of Neurosurgery, University of Pennsylvania School of Medicine, 36th and Hamilton Walk, Philadelphia, PA 19104, USA.
Abstract:
Gliomas are primary central nervous system tumors that arise from astrocytes, oligodendrocytes, or their precursors. Gliomas can be classified into several groups according to histological features. A number of genetic alterations have been identified in human gliomas; these generally affect either signal transduction pathways activated by receptor tyrosine kinases or cell cycle growth arrest pathways. These observed genetic alterations are now being used to complement histopathological diagnosis. The aim of the present review is to give a broad overview of the receptor tyrosine kinase signaling machinery involved in gliomagenesis, with an emphasis on the cooperative interaction between receptor tyrosine kinase signaling and the cell cycle-regulatory machinery. Understanding molecular features of primary glial tumors will eventually allow for target-selective intervention in distinct glioma subsets and a more rational approach to adjuvant therapies for these refractory diseases.
Insights
This review explores receptor tyrosine kinase signaling in glioma development. Understanding these pathways and their interaction with cell cycle regulators can lead to targeted therapies for brain tumors.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Genetics
Background:
- Gliomas are primary brain tumors originating from glial cells.
- Histological classification is standard, but genetic alterations are increasingly important.
- Genetic changes often involve receptor tyrosine kinase (RTK) pathways or cell cycle control.
Purpose of the Study:
- To review the role of RTK signaling in gliomagenesis.
- To emphasize the interplay between RTK signaling and cell cycle regulation.
- To highlight the potential for targeted therapies based on molecular profiles.
Main Methods:
- Literature review of gliomagenesis.
- Analysis of genetic alterations in gliomas.
- Focus on RTK and cell cycle pathway interactions.
Main Results:
- RTK signaling pathways are frequently altered in gliomas.
- Cooperative interactions exist between RTK signaling and cell cycle machinery.
- Genetic insights complement histopathological diagnosis.
Conclusions:
- Understanding molecular pathways is crucial for glioma treatment.
- Targeted interventions can be developed for specific glioma subsets.
- Molecular knowledge aids in designing rational adjuvant therapies for refractory gliomas.
More Related Videos
09:23Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
Published on: October 20, 2016
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades